Overview
5-Amino-1MQ is a small-molecule inhibitor commonly used to study NNMT (nicotinamide N-methyltransferase)—an enzyme that links methyl-donor use (SAM/SAH cycle) with NAD⁺ salvage and cellular energy programs.
Key research highlights (in plain terms)
-
Targeted enzyme inhibition — used to selectively inhibit NNMT, helping researchers map how cells handle methylation balance and NAD⁺ availability under controlled conditions.
-
Metabolism readouts — applied in models tracking NAD⁺/NADH ratios, 1-methylnicotinamide (MNA) levels, and downstream signals (e.g., sirtuin/PARP-related panels) to connect enzyme activity with measurable outcomes.
-
Cell & tissue models — suitable for adipocyte, hepatocyte, and myocyte systems examining energy use, lipid handling, and transcriptional responses to pathway modulation.
-
Dose–response & selectivity — supports clear concentration–effect curves, off-target screening, and time-course studies for robust assay design.
-
Comparative assays — useful alongside other NAD⁺-pathway modulators to differentiate mechanism, potency, and pathway bias in standardized setups.
Why Pegasus
-
Clarity in every vial: straightforward specs and labeling
Specifications
-
Type: Small-molecule NNMT inhibitor (research grade)
-
Form: Lyophilized/crystalline powder
-
Appearance: White to off-white
-
Purity: no third-party certificate is currently published for this product
-
Solubility: DMSO (preferred stock solvent); dilute into appropriate aqueous buffer per protocol
-
Packaging: Labeled container
Storage & handling
-
Store dry at −20 °C, protected from light and moisture
Included with your order
-
Labeled container of 5-Amino-1MQ (research grade)





